AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
QUETIAPINE
24 registrations across 2 African markets— 2 active
Markets with QUETIAPINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| O-QUETIA 100 TABLETS | 🇬🇭Ghana | — | active | Dec 2028 |
| O-QUETIA 100 TABLETS | 🇬🇭Ghana | — | active | Dec 2028 |
| QUETAP 50 Comprimé pelliculé / 50 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Apr 2019 |
| QUETIAPINE SANDOZ Comprimé pelliculé / 100 mg | 🇹🇳Tunisia | SANDOZ GmbH | expired | Jul 2017 |
| QUETIAPINE SANDOZ Comprimé pelliculé / 200 mg | 🇹🇳Tunisia | SANDOZ GmbH | expired | Jul 2017 |
| QUETIAPINE SANDOZ Comprimé pelliculé / 300 mg | 🇹🇳Tunisia | SANDOZ GmbH | expired | Jul 2017 |
| QUETIAPINE SANDOZ Comprimé pelliculé / 25 mg | 🇹🇳Tunisia | SANDOZ GmbH | expired | Jul 2017 |
| QUETAP Comprimé pelliculé / 50 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Jun 2017 |
| QUETAP 25 Comprimé pelliculé / 25 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | May 2017 |
| QUETAP Comprimé pelliculé / 300 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Feb 2017 |
| QUETAP Comprimé pelliculé / 200 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Jan 2017 |
| QUETAP Comprimé pelliculé / 100 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Jan 2017 |
| QUETAP Comprimé pelliculé / 25 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Nov 2016 |
| QUETAP Comprimé pelliculé / 200 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Nov 2016 |
| QUETAP Comprimé pelliculé / 300 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Nov 2016 |
| QUETAP Comprimé pelliculé / 100 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Nov 2016 |
| SEROQUEL XL Comprimé à libération prolongée / 200 mg | 🇹🇳Tunisia | ASTRA ZENECA UK Ltd | expired | Feb 2013 |
| SEROQUEL XL Comprimé à libération prolongée / 400 mg | 🇹🇳Tunisia | ASTRA ZENECA UK Ltd | expired | Dec 2012 |
| SEROQUEL XL Comprimé à libération prolongée / 50 mg | 🇹🇳Tunisia | ASTRA ZENECA UK Ltd | expired | Dec 2012 |
| SEROQUEL XL Comprimé à libération prolongée / 300 mg | 🇹🇳Tunisia | ASTRA ZENECA UK Ltd | expired | Dec 2012 |
| SEROQUEL Comprimé pelliculé / 100 mg | 🇹🇳Tunisia | ASTRA ZENECA UK Ltd | expired | May 2010 |
| SEROQUEL Comprimé pelliculé / 300 mg | 🇹🇳Tunisia | ASTRA ZENECA UK Ltd | expired | May 2010 |
| SEROQUEL Comprimé pelliculé / 25 mg | 🇹🇳Tunisia | ASTRA ZENECA UK Ltd | expired | May 2010 |
| SEROQUEL Comprimé pelliculé / 200 mg | 🇹🇳Tunisia | ASTRA ZENECA UK Ltd | expired | May 2010 |
QUETIAPINE in Africa — Regulatory Overview
QUETIAPINE is registered across 2 African markets with 24 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Ghana. AfricaRegulatory refreshes this data daily from official government sources.
Of the 24 registrations, 2 (8%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.